+91 8766 590 1366 sales@chemreports.com

Your Order

Home Reports

Abiraterone Acetate API Global Market

Abiraterone Acetate API Global Market

Global Abiraterone Acetate API Market Research Report 2025

This report on the global abiraterone acetate api market research report 2025 offers a comprehensive analysis of market size, growth drivers, emerging trends, region

Pages: 210

Format: PDF

Date: 12-2025

Select Licence

Description Table of Content Key Players & Segment Request for Free Sample

Global Abiraterone Acetate API Market Overview

The Global Abiraterone Acetate API Market represents a strategically significant segment of the oncology-focused active pharmaceutical ingredient (API) industry. Abiraterone Acetate is a critical API used in hormone therapy for prostate cancer, and its demand is closely linked to the rising global prevalence of hormone-dependent cancers, increasing life expectancy, and broader access to generic oncology drugs.

Chem Reports estimates that the Abiraterone Acetate API Market was valued at USD xxxx units in 2024 and is projected to reach USD xxxx units by 2035, expanding at a CAGR of xx% during the forecast period (2025–2035). Market growth is primarily driven by the expiration of patents on branded formulations, increasing penetration of cost-effective generics, and sustained demand from regulated and semi-regulated pharmaceutical markets.

The market analysis incorporates extensive primary and secondary research, evaluating regulatory frameworks, pricing dynamics, supply-chain evolution, manufacturing capacity, technological advancements in API synthesis, and competitive positioning across key geographies.

Impact of COVID-19 on the Abiraterone Acetate API Market

The COVID-19 pandemic initially disrupted the Abiraterone Acetate API market due to interruptions in raw material supply, manufacturing slowdowns, logistics constraints, and workforce shortages. Lockdowns across major API-producing regions caused short-term production volatility and delayed shipment timelines.

However, the medium- to long-term impact was moderate, as oncology treatments were prioritized across healthcare systems. Post-pandemic recovery was supported by normalization of global supply chains, strategic inventory stocking by pharmaceutical companies, and increased focus on localizing API manufacturing to reduce future dependency risks.

Market Segmentation Analysis

By Type (Purity Level)

Purity ≥ 98%

  • Widely used in semi-regulated and emerging pharmaceutical markets
  • Cost-effective manufacturing profile
  • Suitable for formulations with flexible regulatory thresholds

Purity ≥ 99%

  • Preferred for regulated markets such as the U.S., Europe, and Japan
  • Higher compliance with pharmacopeial and regulatory standards
  • Increasing demand due to stringent quality requirements and bioequivalence norms

By Application

Abiraterone Acetate Tablets

  • Dominant application segment
  • High prescription volume in prostate cancer treatment
  • Broad acceptance across hospital and retail pharmacy channels

Abiraterone Acetate Capsules

  • Niche but growing segment
  • Favored in specific dosage and formulation strategies
  • Growing adoption in patient-centric treatment regimens

Others

  • Includes customized formulations and combination therapies
  • Limited volume but strategically important for innovation-driven manufacturers

Key Players Analysis

The market is moderately consolidated, with strong participation from vertically integrated pharmaceutical and API manufacturers. Key players focus on cost optimization, regulatory approvals, capacity expansion, and long-term supply contracts.

  • Cipla – Strong global presence, robust oncology portfolio, and extensive API manufacturing capabilities.
  • TAPI Teva – Leader in high-quality APIs with strong regulatory compliance in regulated markets.
  • HETERO – Cost-competitive manufacturing and large-scale API production capacity.
  • Sterling S.p.A. – Focused on high-purity APIs for regulated regions.
  • Farmhispania Group – Specialized in complex and oncology APIs.
  • Scion Pharm Taiwan – Regional supplier with strong Asian market penetration.
  • Qilu Pharmaceutical – Large-scale producer with expanding international footprint.
  • Aurisco Pharmaceutical – Focused on advanced intermediates and APIs.
  • Aspen Bio Pharma Labs – Emerging player emphasizing quality-driven production.
  • Shilpa Medicare Limited – Strong oncology focus with integrated API and formulation operations.
  • Shandong Chuangxin Pharmaceutical R&D – R&D-driven API supplier.
  • Zhejiang Xianju Junye Pharmaceutical – Competitive pricing and expanding capacity.
  • Wuhan Sunrise Technology Development – Specialized in pharmaceutical intermediates and APIs.

Regional Analysis

North America

  • Strong demand driven by high prostate cancer incidence
  • Preference for high-purity APIs (≥99%)
  • Stringent regulatory environment supports premium pricing

Europe

  • Stable demand across Western and Central Europe
  • Strong presence of generic drug manufacturers
  • Emphasis on quality, traceability, and compliance

Asia-Pacific

  • Fastest-growing regional market
  • India and China dominate API production and exports
  • Rising domestic demand coupled with export-driven growth

South America

  • Gradual market expansion supported by improving healthcare access
  • Increasing adoption of generic oncology medicines
  • Dependence on imported APIs

Middle East & Africa

  • Emerging market with long-term growth potential
  • Rising cancer awareness and treatment access
  • Limited local API production, high reliance on imports

DRTO Analysis (Drivers, Restraints, Trends & Opportunities)

Drivers

  • Rising global prevalence of prostate cancer and hormone-dependent oncology conditions
  • Expiry of patents on branded Abiraterone Acetate formulations, accelerating generic penetration
  • Increasing demand for cost-effective oncology therapies in emerging economies
  • Expansion of API manufacturing capacity in India and China
  • Growing preference for high-purity APIs in regulated pharmaceutical markets

Restraints

  • Stringent regulatory compliance requirements for oncology APIs
  • High capital investment required for GMP-certified manufacturing facilities
  • Pricing pressure due to intense competition among generic API suppliers
  • Volatility in raw material availability and procurement costs
  • Lengthy approval timelines in regulated regions

Trends

  • Shift toward ≥99% purity APIs to meet stricter regulatory and pharmacopoeial standards
  • Vertical integration by API manufacturers into finished dosage formulations
  • Increasing outsourcing of API production by global pharmaceutical companies
  • Capacity expansion and technology upgrades focused on yield optimization
  • Supply chain diversification to reduce geographic dependency risks

Opportunities

  • Growing oncology drug consumption in Asia-Pacific, Latin America, and Africa
  • Rising demand from contract manufacturing organizations (CMOs)
  • Strategic collaborations between API producers and formulation companies
  • Export growth opportunities in regulated and semi-regulated markets
  • Increasing healthcare spending and cancer awareness programs globally

SWOT Analysis for Key Players

Strengths

  • Established manufacturing infrastructure with economies of scale
  • Strong technical expertise in complex oncology APIs
  • Broad global distribution networks
  • Regulatory approvals across multiple geographies
  • Cost advantages driven by optimized production processes

Weaknesses

  • Heavy dependence on limited therapeutic segments
  • Exposure to regulatory non-compliance risks
  • Margin pressure due to price-based competition
  • Limited brand differentiation at the API level

Opportunities

  • Expansion into high-value regulated markets
  • Development of next-generation oncology APIs
  • Long-term supply agreements with multinational pharmaceutical companies
  • Backward integration into key intermediates
  • Increasing demand for customized and high-purity APIs

Threats

  • Intensifying competition from low-cost manufacturers
  • Sudden regulatory changes impacting production or exports
  • Supply chain disruptions due to geopolitical or environmental factors
  • Entry of new players increasing market fragmentation

Porter’s Five Forces Analysis

Threat of New Entrants – Moderate

High capital investment, regulatory complexity, and technical expertise requirements create entry barriers, though emerging markets still see new capacity additions.

Bargaining Power of Suppliers – Moderate

Limited availability of specialized raw materials gives suppliers some leverage, but large API manufacturers mitigate this through bulk sourcing and backward integration.

Bargaining Power of Buyers – High

Pharmaceutical formulation companies exert strong negotiating power due to multiple API sourcing options and intense price competition.

Threat of Substitutes – Low to Moderate

Limited therapeutic substitutes for Abiraterone Acetate in advanced prostate cancer treatment reduce substitution risk.

Competitive Rivalry – High

Market characterized by numerous regional and global players competing on price, quality, regulatory compliance, and supply reliability.

Investor-Focused Executive Summary

The Global Abiraterone Acetate API Market presents a stable, demand-driven investment opportunity within the oncology pharmaceutical value chain. Sustained growth is supported by rising cancer prevalence, expanding access to generic oncology drugs, and increasing healthcare expenditure across both developed and emerging economies.

From an investment perspective, the market benefits from predictable long-term demand, particularly in regulated regions that prioritize high-quality APIs. While pricing pressure remains a structural challenge, companies with strong regulatory credentials, cost-efficient manufacturing, and diversified customer bases are well positioned to maintain profitability.

Strategic investments in capacity expansion, process innovation, and regulatory approvals are expected to enhance competitive positioning. Asia-Pacific will remain the primary production hub, while North America and Europe will continue to drive value realization through premium pricing and volume stability.

Overall, the Abiraterone Acetate API market offers moderate risk with consistent returns, making it attractive for investors focused on pharmaceutical manufacturing, oncology growth segments, and long-term healthcare fundamentals.

 

1. Market Overview of Abiraterone Acetate API Market
    1.1 Abiraterone Acetate API Market Market Overview
        1.1.1 Abiraterone Acetate API Market Product Scope
        1.1.2 Market Status and Outlook
    1.2 Abiraterone Acetate API Market Market Size by Regions:
    1.3 Abiraterone Acetate API Market Historic Market Size by Regions
    1.4 Abiraterone Acetate API Market Forecasted Market Size by Regions
    1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
        1.5.1 North America
        1.5.2 East Asia
        1.5.3 Europe
        1.5.4 South Asia
        1.5.5 Southeast Asia
        1.5.6 Middle East
        1.5.7 Africa
        1.5.8 Oceania
        1.5.9 South America
        1.5.10 Rest of the World
    1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
        1.6.1 Covid-19 Impact: Global GDP Growth,  Projections
        1.6.2 Covid-19 Impact: Commodity Prices Indices
        1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Abiraterone Acetate API Market Sales Market by Type
    2.1 Global Abiraterone Acetate API Market Historic Market Size by Type
    2.2 Global Abiraterone Acetate API Market Forecasted Market Size by Type
    2.3 Purity ? 98 %
    2.4 Purity ? 99 %
3. Covid-19 Impact Abiraterone Acetate API Market Sales Market by Application
    3.1 Global Abiraterone Acetate API Market Historic Market Size by Application
    3.2 Global Abiraterone Acetate API Market Forecasted Market Size by Application
    3.3 Abiraterone Acetate Tablets
    3.4 Abiraterone Acetate Capsules
    3.5 Others
4. Covid-19 Impact Market Competition by Manufacturers
    4.1 Global Abiraterone Acetate API Market Production Capacity Market Share by Manufacturers
    4.2 Global Abiraterone Acetate API Market Revenue Market Share by Manufacturers
    4.3 Global Abiraterone Acetate API Market Average Price by Manufacturers
5. Company Profiles and Key Figures in Abiraterone Acetate API Market Business
    5.1 Cipla
        5.1.1 Cipla Company Profile
        5.1.2 Cipla Abiraterone Acetate API Market Product Specification
        5.1.3 Cipla Abiraterone Acetate API Market Production Capacity, Revenue, Price and Gross Margin
    5.2 Tapi Teva
        5.2.1 Tapi Teva Company Profile
        5.2.2 Tapi Teva Abiraterone Acetate API Market Product Specification
        5.2.3 Tapi Teva Abiraterone Acetate API Market Production Capacity, Revenue, Price and Gross Margin
    5.3 HETERO
        5.3.1 HETERO Company Profile
        5.3.2 HETERO Abiraterone Acetate API Market Product Specification
        5.3.3 HETERO Abiraterone Acetate API Market Production Capacity, Revenue, Price and Gross Margin
    5.4 Sterling S.P.A. IT
        5.4.1 Sterling S.P.A. IT Company Profile
        5.4.2 Sterling S.P.A. IT Abiraterone Acetate API Market Product Specification
        5.4.3 Sterling S.P.A. IT Abiraterone Acetate API Market Production Capacity, Revenue, Price and Gross Margin
    5.5 Farmhispania Group
        5.5.1 Farmhispania Group Company Profile
        5.5.2 Farmhispania Group Abiraterone Acetate API Market Product Specification
        5.5.3 Farmhispania Group Abiraterone Acetate API Market Production Capacity, Revenue, Price and Gross Margin
    5.6 Scion Pharm Taiwan
        5.6.1 Scion Pharm Taiwan Company Profile
        5.6.2 Scion Pharm Taiwan Abiraterone Acetate API Market Product Specification
        5.6.3 Scion Pharm Taiwan Abiraterone Acetate API Market Production Capacity, Revenue, Price and Gross Margin
    5.7 Qilu Pharmaceutial
        5.7.1 Qilu Pharmaceutial Company Profile
        5.7.2 Qilu Pharmaceutial Abiraterone Acetate API Market Product Specification
        5.7.3 Qilu Pharmaceutial Abiraterone Acetate API Market Production Capacity, Revenue, Price and Gross Margin
    5.8 Aurisco Pharmaceutical
        5.8.1 Aurisco Pharmaceutical Company Profile
        5.8.2 Aurisco Pharmaceutical Abiraterone Acetate API Market Product Specification
        5.8.3 Aurisco Pharmaceutical Abiraterone Acetate API Market Production Capacity, Revenue, Price and Gross Margin
    5.9 Aspen Bio Pharma Labs
        5.9.1 Aspen Bio Pharma Labs Company Profile
        5.9.2 Aspen Bio Pharma Labs Abiraterone Acetate API Market Product Specification
        5.9.3 Aspen Bio Pharma Labs Abiraterone Acetate API Market Production Capacity, Revenue, Price and Gross Margin
    5.10 Shilpa Medicare Limited
        5.10.1 Shilpa Medicare Limited Company Profile
        5.10.2 Shilpa Medicare Limited Abiraterone Acetate API Market Product Specification
        5.10.3 Shilpa Medicare Limited Abiraterone Acetate API Market Production Capacity, Revenue, Price and Gross Margin
    5.11 Shandong Chuangxin Pharmaceutical Research and Development
        5.11.1 Shandong Chuangxin Pharmaceutical Research and Development Company Profile
        5.11.2 Shandong Chuangxin Pharmaceutical Research and Development Abiraterone Acetate API Market Product Specification
        5.11.3 Shandong Chuangxin Pharmaceutical Research and Development Abiraterone Acetate API Market Production Capacity, Revenue, Price and Gross Margin
    5.12 Zhejiang Xianju Junye Pharmaceutical
        5.12.1 Zhejiang Xianju Junye Pharmaceutical Company Profile
        5.12.2 Zhejiang Xianju Junye Pharmaceutical Abiraterone Acetate API Market Product Specification
        5.12.3 Zhejiang Xianju Junye Pharmaceutical Abiraterone Acetate API Market Production Capacity, Revenue, Price and Gross Margin
    5.13 Wuhan Sunrise Technology Development
        5.13.1 Wuhan Sunrise Technology Development Company Profile
        5.13.2 Wuhan Sunrise Technology Development Abiraterone Acetate API Market Product Specification
        5.13.3 Wuhan Sunrise Technology Development Abiraterone Acetate API Market Production Capacity, Revenue, Price and Gross Margin
6. North America
    6.1 North America Abiraterone Acetate API Market Market Size
    6.2 North America Abiraterone Acetate API Market Key Players in North America
    6.3 North America Abiraterone Acetate API Market Market Size by Type
    6.4 North America Abiraterone Acetate API Market Market Size by Application
7. East Asia
    7.1 East Asia Abiraterone Acetate API Market Market Size
    7.2 East Asia Abiraterone Acetate API Market Key Players in North America
    7.3 East Asia Abiraterone Acetate API Market Market Size by Type
    7.4 East Asia Abiraterone Acetate API Market Market Size by Application
8. Europe
    8.1 Europe Abiraterone Acetate API Market Market Size
    8.2 Europe Abiraterone Acetate API Market Key Players in North America
    8.3 Europe Abiraterone Acetate API Market Market Size by Type
    8.4 Europe Abiraterone Acetate API Market Market Size by Application
9. South Asia
    9.1 South Asia Abiraterone Acetate API Market Market Size
    9.2 South Asia Abiraterone Acetate API Market Key Players in North America
    9.3 South Asia Abiraterone Acetate API Market Market Size by Type
    9.4 South Asia Abiraterone Acetate API Market Market Size by Application
10. Southeast Asia
    10.1 Southeast Asia Abiraterone Acetate API Market Market Size
    10.2 Southeast Asia Abiraterone Acetate API Market Key Players in North America
    10.3 Southeast Asia Abiraterone Acetate API Market Market Size by Type
    10.4 Southeast Asia Abiraterone Acetate API Market Market Size by Application
11. Middle East
    11.1 Middle East Abiraterone Acetate API Market Market Size
    11.2 Middle East Abiraterone Acetate API Market Key Players in North America
    11.3 Middle East Abiraterone Acetate API Market Market Size by Type
    11.4 Middle East Abiraterone Acetate API Market Market Size by Application
12. Africa
    12.1 Africa Abiraterone Acetate API Market Market Size
    12.2 Africa Abiraterone Acetate API Market Key Players in North America
    12.3 Africa Abiraterone Acetate API Market Market Size by Type
    12.4 Africa Abiraterone Acetate API Market Market Size by Application
13. Oceania
    13.1 Oceania Abiraterone Acetate API Market Market Size
    13.2 Oceania Abiraterone Acetate API Market Key Players in North America
    13.3 Oceania Abiraterone Acetate API Market Market Size by Type
    13.4 Oceania Abiraterone Acetate API Market Market Size by Application
14. South America
    14.1 South America Abiraterone Acetate API Market Market Size
    14.2 South America Abiraterone Acetate API Market Key Players in North America
    14.3 South America Abiraterone Acetate API Market Market Size by Type
    14.4 South America Abiraterone Acetate API Market Market Size by Application
15. Rest of the World
    15.1 Rest of the World Abiraterone Acetate API Market Market Size
    15.2 Rest of the World Abiraterone Acetate API Market Key Players in North America
    15.3 Rest of the World Abiraterone Acetate API Market Market Size by Type
    15.4 Rest of the World Abiraterone Acetate API Market Market Size by Application
16 Abiraterone Acetate API Market Market Dynamics
    16.1 Covid-19 Impact Market Top Trends
    16.2 Covid-19 Impact Market Drivers
    16.3 Covid-19 Impact Market Challenges
    16.4 Porter?s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
    18.1 Research Methodology
        18.1.1 Methodology/Research Approach
        18.1.2 Data Source
    18.2 Disclaimer

Market Segmentation Analysis

By Type (Purity Level)

Purity ≥ 98%

  • Widely used in semi-regulated and emerging pharmaceutical markets
  • Cost-effective manufacturing profile
  • Suitable for formulations with flexible regulatory thresholds

Purity ≥ 99%

  • Preferred for regulated markets such as the U.S., Europe, and Japan
  • Higher compliance with pharmacopeial and regulatory standards
  • Increasing demand due to stringent quality requirements and bioequivalence norms

By Application

Abiraterone Acetate Tablets

  • Dominant application segment
  • High prescription volume in prostate cancer treatment
  • Broad acceptance across hospital and retail pharmacy channels

Abiraterone Acetate Capsules

  • Niche but growing segment
  • Favored in specific dosage and formulation strategies
  • Growing adoption in patient-centric treatment regimens

Others

  • Includes customized formulations and combination therapies
  • Limited volume but strategically important for innovation-driven manufacturers

Key Players Analysis

The market is moderately consolidated, with strong participation from vertically integrated pharmaceutical and API manufacturers. Key players focus on cost optimization, regulatory approvals, capacity expansion, and long-term supply contracts.

  • Cipla – Strong global presence, robust oncology portfolio, and extensive API manufacturing capabilities.
  • TAPI Teva – Leader in high-quality APIs with strong regulatory compliance in regulated markets.
  • HETERO – Cost-competitive manufacturing and large-scale API production capacity.
  • Sterling S.p.A. – Focused on high-purity APIs for regulated regions.
  • Farmhispania Group – Specialized in complex and oncology APIs.
  • Scion Pharm Taiwan – Regional supplier with strong Asian market penetration.
  • Qilu Pharmaceutical – Large-scale producer with expanding international footprint.
  • Aurisco Pharmaceutical – Focused on advanced intermediates and APIs.
  • Aspen Bio Pharma Labs – Emerging player emphasizing quality-driven production.
  • Shilpa Medicare Limited – Strong oncology focus with integrated API and formulation operations.
  • Shandong Chuangxin Pharmaceutical R&D – R&D-driven API supplier.
  • Zhejiang Xianju Junye Pharmaceutical – Competitive pricing and expanding capacity.
  • Wuhan Sunrise Technology Development – Specialized in pharmaceutical intermediates and APIs.

Upto 24 to 48 hrs (Working Hours)

Upto 72 hrs max (Working Hours) - Weekends and Public Holidays

Single User License - Allows access to only one person to the report.

Multi User License - Allows sharing with max 5 persons within organization.

Corporate License – Can be shared across entire organization.

Online Payments with PayPal

Wire Transfer / Bank Transfer

Why Choose Us

24/7 Expert Support

At ChemReports, we understand that business decisions can’t wait. Our research specialists are available anytime to answer your queries and guide you through our reports, ensuring quick and reliable assistance.

Comprehensive Market Coverage

ChemReports provides 360° market analysis across materials, technologies, and global chemical sectors—helping you make confident business decisions.

Actionable Intelligence

We turn complex data into strategic insights to support fact-based decisions, market entry strategies, and competitive analysis.

Data Privacy & Security

Your personal and business information is completely secure with us. We value your trust and ensure strict confidentiality.

Customized Research

Need tailored insights? Our analysts provide custom reports built on authentic data and aligned with your specific business goals.

FAQs

Yes, we are providing all research support to get resolve all queries and concerns regarding the report. For all our clients.
Yes, we are providing complete customization in every report to fulfill your business needs.
Yes, we are providing regional and countries level analysis in the report, please mention the countries you are looking.
Yes, we are providing a discount for individuals and startups.
We offer access to more than one million market research reports. If the specific topic you need is not listed on our website, simply email us your requirements at sales@chemreports.com. Our research team will review your request and provide a customized report or the most relevant available study. We?re always happy to assist you with tailored solutions.